-
-
-
-
-
-
-
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth
-
-
-
-
-
-
-
QIAGEN to acquire Parse Biosciences for $225 million
-
-
-
-
-
-
-
QIAGEN receives FDA clearance for higher-throughput diagnostic system
-
-
-
-
-
-
-
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
-
-
-
-
-
-
-
Qiagen (QGEN) Acquires Genoox AI-powered software
-
-
-
-
-
-
-
QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting
-
-
-
-
-
-
-
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

